Author: Dr. David Lowemann

Study: GLP-1s That Achieve the Most Weight Loss

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. A new evidence review published in the Annals of Internal Medicine shows that the widely-known drugs tirzepatide (Zepbound) and… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on January 8, 2025

Two RSV Shots to Carry Neurological Risk Warning

GSK and Pfizer’s respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on Tuesday. The regulator conducted a postmarketing trial which suggested… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of […]

Published on January 8, 2025

Study Finds Volunteering Slows Biological Aging

If you want to slow your biological aging in 2025, try volunteering. A study of 2,605 men and women aged 62 and older, published in the January edition of Social Science & Medicine, found that those who volunteered one to four hours per week experienced slower biological… Read Full Article (External Site) Dr. David LowemannDr. […]

Published on January 7, 2025